APELLIS PHARMACEUTICALS, INC
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2008-01-01
- Employees
- 706
- Market Cap
- $4.8B
- Website
- http://www.apellis.com
Pilot Study to Assess Safety, Preliminary Efficacy and Pharmacokinetics of S.C. Pegcetacoplan (APL-2) in PNH Subjects.
- First Posted Date
- 2015-10-28
- Last Posted Date
- 2021-01-11
- Lead Sponsor
- Apellis Pharmaceuticals, Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT02588833
- Locations
- 🇳🇿
Waikato Hospital, Hamilton, Waikato, New Zealand
🇲🇾Hospital Ampang, Ampang, Selangor, Malaysia
🇹🇭Ramathibodi Hospital, Bangkok, Thailand
Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy
- First Posted Date
- 2015-07-20
- Last Posted Date
- 2020-10-06
- Lead Sponsor
- Apellis Pharmaceuticals, Inc.
- Target Recruit Count
- 246
- Registration Number
- NCT02503332
- Locations
- 🇺🇸
The Gavin Herbert Eye Institute/UC Irvine, Irvine, California, United States
🇺🇸University of Southern California - USC Eye Institute, Los Angeles, California, United States
🇺🇸Associated Retinal Consultants, PC, Traverse City, Michigan, United States
Assessment of Safety, Tolerability and Pharmacokinetics of Intravitreal Pegcetacoplan (APL-2) for Patients With Wet AMD
- Conditions
- Neovascular Age-Related Macular Degeneration
- Interventions
- First Posted Date
- 2015-06-03
- Last Posted Date
- 2020-10-06
- Lead Sponsor
- Apellis Pharmaceuticals, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT02461771
- Locations
- 🇺🇸
United States, Florida, Miami, Florida, United States
🇺🇸United States, California, Beverly Hills, California, United States
🇦🇺Australia, New South Wells, Parramatta, New South Wales, Australia
A Phase I Study to Assess the Safety of Pegcetacoplan (APL-2) as an Add-On to Standard of Care in Subjects With PNH
- First Posted Date
- 2014-10-15
- Last Posted Date
- 2021-01-08
- Lead Sponsor
- Apellis Pharmaceuticals, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT02264639
- Locations
- 🇺🇸
University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸Lakes Research, Miami Lakes, Florida, United States
🇺🇸Cleveland Clinic, Cleveland, Ohio, United States